These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9425582)

  • 1. Maternal serum biochemical screening for pregnancy complications other than aneuploidy.
    Pahal GS; Jauniaux E
    Curr Opin Obstet Gynecol; 1997 Dec; 9(6):379-86. PubMed ID: 9425582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
    Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
    Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
    Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
    J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated human chorionic gonadotropin levels in pregnancies with sex chromosome abnormalities.
    Barnes-Kedar I; Amiel A; Maor O; Fejgin M
    Am J Med Genet; 1993 Feb; 45(3):356-7. PubMed ID: 8434623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse outcome of pregnancies with extremely high levels of maternal serum human chorionic gonadotropin.
    Sharony R; Itzhaky D; Amiel A; Hershko A; Grinshpoon Y; Fejgin M
    Fetal Diagn Ther; 2008; 23(3):233-6. PubMed ID: 18417984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
    Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
    Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
    J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HELLP syndrome: its association with unexplained elevation of MSAFP and MShCG in the second trimester.
    Morssink LP; Heringa MP; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1997 Jul; 17(7):601-6. PubMed ID: 9249859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
    Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
    Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening.
    Harper MA; Ruiz C; Pettenati MJ; Rao PN
    Obstet Gynecol; 1994 May; 83(5 Pt 2):844-6. PubMed ID: 7512706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
    Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
    BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
    Lambert-Messerlian G; Pinar H; Rubin LP; De Paepe ME; Tantravahi U; Steinhoff MM; Russell M; Canick JA
    Pediatr Dev Pathol; 2005; 8(2):230-4. PubMed ID: 15765203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sensitivity of the trivariate analysis using maternal serum alpha-feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35.
    Anandakumar C; Chew S; Wong YC; Goh VH; Tain CF; Ratnam SS
    J Perinat Med; 1999; 27(3):178-82. PubMed ID: 10503178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between unexplained elevated maternal serum alpha fetoprotein and/or human chorionic gonadotropin and the occurrence of placental thrombotic lesions.
    Salim R; Okopnik M; Garmi G; Nachum Z; Zafran N; Shalev E
    Placenta; 2010 Apr; 31(4):277-81. PubMed ID: 20132984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum alpha-fetoprotein in the diagnosis of hydatidiform mole. A report of two cases with elevated levels of maternal serum AFP.
    Toftager-Larsen K; Petersen PL; Nørgaard-Pedersen B
    Dan Med Bull; 1981 Aug; 28(3):123-4. PubMed ID: 6168433
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased maternal serum human chorionic gonadotropin concentrations are an independent risk factor for SGA in dichorionic twin gestations.
    Hershkovitz R; Bar G; Erez O; Smolin A; Sheiner E; Mishori-Dery A; Mazor M
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):117-22. PubMed ID: 16203597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
    Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
    Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
    Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.